SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure and volatility as investors weigh the impact of an ongoing OpenAI-related legal battle against the company's broader AI integration and cloud infrastructure strategy. While community sentiment remains divided between those viewing the current price weakness as a long-term accumulation opportunity and those frustrated by its relative underperformance compared to other mega-cap tech, active discussions highlight a rotation toward software monetization and potential catalysts from upcoming legal proceedings.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is rallying to record highs as reports of U.S. approval for advanced chip sales to major Chinese firms alleviate long-standing trade concerns. The community is actively debating whether this momentum will carry the stock toward higher valuation milestones ahead of next week's earnings or if the rapid price appreciation has created a precarious bubble.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following a strong quarterly earnings report featuring revenue growth that beat analyst expectations and raised full-year guidance, fueled by accelerating enterprise adoption of its AI-powered features. Community sentiment is heavily focused on a potential short squeeze, with investors highlighting significant short interest and arguing that the companys strong net dollar retention and essential role in design workflows prove its long-term value despite broader market concerns about AI competition.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors gear up for a plenary oral presentation at the American Urological Association annual meeting, where the company will share extended Phase 3 trial data for its prostate cancer immunotherapy. The community is actively debating the significance of the upcoming clinical update, focusing on the potential for curative-intent benefits and speculating on whether the trial results could drive a major re-rating or acquisition interest.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing intense volatility as traders debate whether the current price action signals a healthy cooling period or a structural collapse for the overbought semiconductor sector. The community is sharply divided, with bulls aggressively buying the dip on AI growth narratives, while bears point to extreme technical valuations and the potential for a deeper, long-term retracement.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are weighing geopolitical tensions and rising bond yields against high-profile trade optimism following summit meetings in Beijing. Community discussion is heavily divided, with some traders anticipating a technical correction or 'V-shaped' recovery, while others express caution over stretched equity valuations and potential volatility surrounding monthly options expiration.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Investors are actively debating the market's sustainability as QQQ hits record highs, with the community split between those riding the AI-fueled momentum and bears pointing to historical overvaluation and potential volatility from upcoming options expiration. While some traders are aggressively buying dips expecting continued gains, others warn that underlying macroeconomic headwinds and extreme sentiment indicators suggest a potential correction is on the horizon.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is seeing intense market activity driven by a strategic $100 million investment from the Winklevoss Capital Fund, alongside better-than-expected quarterly revenue figures and growth in its card services. Investors are actively debating the potential for a short squeeze due to high short interest, while community discussions remain divided between speculative bullishness regarding potential Russell 2000 inclusion and concerns over the company's long-term financial health and legal challenges.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is facing significant volatility as investors weigh disappointing Q1 earnings and production delays against a massive long-term growth narrative fueled by government contracts and critical mineral demand. While the stock has seen a sharp pullback, the community remains deeply divided between those betting on a major squeeze driven by high short interest and institutional accumulation, and skeptics who are increasingly frustrated by the company's inconsistent operational execution.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending after President Trump announced a deal for China to purchase 200 Boeing jets, a move that has fueled community debate over whether the order size fell short of high market expectations or represents a significant thawing of trade relations. While some investors view the deal as a major catalyst for long-term recovery and cash flow, others are expressing frustration over the stock's volatility and the influence of hedge fund positioning on the price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TD Cowen Issues Positive Forecast for NeoGenomics (NASDAQ:NEO) Stock Price

TD Cowen boosted their target price on shares of NeoGenomics from $13.00 to $14.00 and gave the company a "buy" rating in a research note on Wednesday...

NeoGenomics (NASDAQ:NEO) Shares Gap Up Following Analyst Upgrade

NeoGenomics (NASDAQ:NEO) Shares Gap Up on Analyst Upgrade...

Wall Street’s Next Biotech Winners Emerge as FDA Acceleration Unleashes New Markets

The biotech and health-tech landscape is entering a new acceleration phase, driven by regulatory momentum, AI integration, and a surge in precision medicine.  $NEO, $TGNT, $XTLB, $SAGT, $PRCH, $AKAN

NeoGenomics (NASDAQ:NEO) Upgraded by Leerink Partners to Outperform Rating

Leerink Partners upgraded NeoGenomics from a "market perform" rating to an "outperform" rating and increased their target price for the company from $12.00 to $25.00 in a research report on Wednesday...

NeoGenomics (NASDAQ:NEO) Announces Quarterly Earnings Results, Hits Estimates

NeoGenomics (NASDAQ:NEO - Get Free Report) released its earnings results on Tuesday. The medical research company reported $0.01 earnings per share for the quarter, meeting analysts' consensus...

NeoGenomics Q1 Earnings Call Highlights

NeoGenomics (NASDAQ:NEO) reported first-quarter 2026 results that management said reflected continued momentum in its clinical business and growing contributions from newer, higher-value oncology...

NeoGenomics (NEO) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

NeoGenomics (NEO) Q1 2025 Earnings Transcript

NeoGenomics Reports First Quarter 2026 Results

NeoGenomics, Inc. (NASDAQ: NEO) (the Company), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced its first quarter results for the period ended March...

NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that its oncology testing portfolio is now available through Epic...

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

NEO
Neogenomics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest NEO News

NEONeogenomics Inc.